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55 1. Inventer la biome´decine in historiographical context
56 ‘Among Western European nations France has been known for its anti-American-
57 ism’. So opens Richard Kuisel’s Seducing the French (Kuisel, 1993, p. i).1 Rooted
58 in a rich body of writing dating back to the 1920s and 1930s, this anti-Americanism
59 has largely been the prerogative of left-wing intellectuals. However, Kuisel, an
60 American historian living and studying in France, has also observed that ‘recently,
61 in contrast, [France . . .] seemed to succumb to the American way of life’ (Kuisel,
62 1993, p ix). This observation led him to write Seducing the French in an attempt
63 ‘to understand better how France became modern or “Americanized”, and yet
64 remained French’:
65 If we [Americans] were a mirror before which the French saw themselves, we
66 were also a tangible social landscape that the French experienced. If anti- (and
67 pro-) Americanism was, at one level, a reflectio of French thought about personal
68 identity and the future, it was also a confrontation with the content of postwar
69 America. America and Americanization were realities that the French—poli-
70 ticians, visitors, or those surveyed by opinion polls—had to face after 1945. The
71 United States was a superpower that provided security and exerted enormous
72 influenc on postwar Western Europe. Americanization was a process of economic
1
289
533
1
41
2
3
4
5
12
1
2
3
4
5
6
1 22
3
73 modernization, and America was the f rst consumer society and possibly a harbin-
74 ger of Europe’s future. (Kuisel, 1993, pp. xi–xii)
75 The Americanisation of France occurred as through a number of postwar encoun-
76 ters between the two nations brought on by the economic and political imperatives
77 of reconstruction and the Cold War, from the Blum–Byrnes accords, nato, the Mar-
78 shall Plan and the Schuman and Pleven Plans, to American military intervention in
79 Indochina. Describing how the French biomedical complex was created in the ‘mirror
80 of America’ as a result of an increasing number of transatlantic exchanges of men,
81 materials, and ideas (pp. 32–3, 376),2 Inventer la biome´decine therefore joins the
82 mainstream literature on the impact of America on postwar France. In addition to
83 Seducing the French, this literature includes several articles in a special issue of
84 French Historical Studies on France since 1945 (Mulholland, 1991), and The United
85 States and the making of postwar France (Wall, 1991). A growing proportion of the
86 historiography, however, is concerned with the history of science and technology.
87 Focusing chief y on atomic policy and nuclear power (Goldschmidt, 1964; Weart,
88 1979; Pace, 1991; Hecht, 1998), it shows how the French postwar nuclear programme
89 became central to French national identity and was often def ned in opposition to
90 America despite it being a continuation of wartime collaborations between American,
91 British, Canadian, and French scientists.3
92 In contrast, relatively little has been written about the impact of the United States
93 on the French biomedical sciences. In their introduction to the co-edited volume Les
94 sciences biologiques et me´dicales en France, 1920–1950, Debru and Gayon justify
95 the study of science in a French national context in terms of a social, as opposed
96 to intellectual history. Such a history, they argue, is not only better able to show
97 how the rise of the nation states inf uenced scientif c practices, it can also account
98 for national trends, in particular the stagnation of French science after the First World
99 War (Debru & Gayon, 1994, pp. 11–12). However, although Les sciences biologiques
100 et me´dicales includes two chapters on English views of French physiology (the title
101 of one, ‘the other side of the mirror’, using the mirror metaphor once again) and
102 although it recognizes the importance of Franco-American collaboration in genetics,
103 the work largely eschews the question of foreign, more specif cally American inf u-
104 ences on French biological and medical sciences.
105 Until now, this question of American inf uence has almost always been addressed
106 in histories of the Rockefeller Foundation (Zallen, 1989, 1991; Picard, 1999). Long
107 acknowledged as the predominant ‘modernising’ inf uence on the natural sciences
108 in the western world,4 the Rockefeller Foundation had special ties to France since
109 the early twentieth century. These histories generally conclude that its inf uence on
110 French science was considerable, particularly after the Second World War, through
111 the Foundation’s equipment and conference grant programmes (Mulholland, 1991).
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112 Although French scientists maintained their independence and pursued their own
113 agenda, their need to share equipment, along with new links forged between scientists
114 at conferences, encouraged group efforts and teamwork in a way that might not have
115 been possible before—under what Rockefeller off cials saw as the French tendency
116 ‘for isolated, unintegrated research efforts’ (Zallen, 1989, p. 57). This new, collabor-
117 ative way of doing science contributed to the rise of new multi-disciplinary
118 approaches of the kind that blossomed in the early 1960s with the French Nobel
119 Prize-winning work on genetic regulation (Debru & Gayon, 1994, p. 16).5
120 It is interesting to note that much of the literature so far cited has American
121 authors; French historians have tended to avoid the issue of American inf uence on
122 their scientif c and technical culture, which perhaps more than other area of culture
123 has become central to French identity (Guerlac, 1964; Paul, 1985; Hecht, 1998).
124 This may not only ref ect the American fascination with the French fascination with
125 America (Hecht, 1998, p. 39), but also the ambiguous feelings of French cultural
126 e´lites towards the United States. Inventer la biome´decine breaks with this tradition;
127 it tackles the issue of the American legacy in the French biomedical sciences head-
128 on. According to Gaudillie`re, this legacy consists of the creation of a French biomed-
129 ical complex, which he def nes by analogy with the American ‘scientif c-military-
130 industrial complex’ that emerged during the war (p. 15), and with the biomedical
131 complex that followed (p. 16). Gaudillie`re’s study is based on an extensive body of
132 English and French-language literature on the biomedical sciences, including his own
133 publications in the f eld, and on research he has carried out in French and American
134 archives. This is the f rst respect in which Gaudillie`re’s book is an important contri-
135 bution to mainstream as well as to more specialist historiography. It is all the more
136 important that in Franco-American relations (including scientif c and technical
137 relations) lies an explanation of the fundamental socioeconomic and cultural changes
138 of the postwar years. In the case of France these have been referred to as the ‘new
139 French Revolution’ (Kuisel, 1993, pp. ix, xii), or ‘ Les Trente Glorieuses’ (p. 12).
140 Gaudillie`re concludes, as have many authors writing about the Rockefeller Foun-
141 dation, that while American inf uence was crucial it also had its limitations. However,
142 unlike these authors, Gaudillie`re takes this analysis one step further. At one level,
143 he shows how French scientists were not only actively engaged in the transfer of
144 instruments, materials, and results, which they selected to suit their own research
145 interests (p. 374), but also in the production of images of America to be used in the
146 reconstruction of French science after the war (p. 376). At another level, he examines
147 how instruments, techniques, and artefacts—such as the ultracentrifuge, the electron
148 microscope, radioactive isotopes, and a variety of biological and chemical mol-
149 ecules—were imported across the Atlantic, and were subsequently adapted and trans-
150 formed by local French scientif c networks. As ‘boundary objects’, these contributed
151 to making the new f eld of natural knowledge that became ‘biomedicine’ in a French
152 context (Starr and Griesemer, 1988; Golinsky, 1998).
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153 The second way in which Gaudillie`re’s book represents an important contribution
154 is in his detailed approach to the subject, which privileges the study of the material
155 culture of laboratories. Gaudillie`re’s approach is double. In the f rst instance he uses
156 a social constructivist approach attributed to the Social Studies movement. This
157 movement has highlighted the role of controversies, of material culture, and of his-
158 torical context in the development of scientif c knowledge (pp. 17–18). However, I
159 would add that this movement has been greatly enriched by cross-national readings,
160 in particular of the French philosopher Michel Foucault (see, for example, Jordanova,
161 1995), and by multi-disciplinary collaborations between French and English-speaking
162 sociologists, philosophers, and historians of science and medicine. These have been
163 the product of an increasing number of transatlantic as well as cross-Channel
164 exchanges (for example Latour and Woolgar, 1986; Callon, 1987; Hughes and Pinch,
165 1987). Thus, Gaudillie`re’s choice of the title Inventer la biome´decine not only ref ects
166 the book’s content, but also situates it within a body of work on related topics using
167 similar approaches (such as Harden, 1980).
168 In a second instance, Gaudillie`re adopts a micro-analytical approach, one which
169 has gathered pace in recent years.6 According to him, the interest of the detailed,
170 local studies upon which Inventer la biome´decine is based lies not so much in that
171 they avoid the pitfalls of wide-sweeping generalisations, but rather in that they allow
172 the close investigation of the processes involved in the construction of new scientif c
173 facts, artefacts, and research f elds (p. 18). A striking illustration of this is given in
174 the chapter on Pierre Le´pine, who directed the virology department at the Pasteur
175 Institute. Gaudillie`re describes how the study of viruses—such as the polio virus—
176 in this department depended almost entirely on the transfer of information, protocols,
177 plans, and biological materials from American laboratories during and after the
178 Second World War. However, Gaudillie`re also shows how Le´pine’s adaptation and
179 application of the ultracentrifuge was steeped in the Pasteurian tradition of bacterio-
180 logical research associated with the production of vaccines. Therefore, unlike his
181 American counterparts Wendell Stanley and Jonas Salk, Le´pine was neither a
182 biophysical instrument builder, nor a biological expert providing consultancy services
183 for a f rm or foundation. Rather, he was a ‘one man band’ (p. 146), who collected
184 materials, designed experiments, organised trials, and supervised the construction of
185 a production plant. Nevertheless, like his American counterparts and like his col-
186 leagues at the Pasteur Institute engaged in the study of micro-organisms, through
187 the use of physical instrumentation Le´pine took an active part in the development
188 of a new vision of viruses as macromolecules (p. 117). Thus, by focusing on individ-
189 ual case studies ranging from the production and evaluation of antibiotics (ca. 1945),
190 to the collaborative networks and research practices of biochemists (ca. 1965), Gaud-
191 illie`re shows how after the Second World War French biomedicine was ‘invented’
192 in the laboratory and in the clinic as a result of the transfer of skills, apparatuses,
193 and results from America to France, but also, in the case of molecular biology (Ch.
194 7), back across the Atlantic in a reciprocal system of exchange.
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195 Inventer la biome´decine loosely follows the standard chronological order of polit-
196 ical histories: the period of post-war reconstruction (1945–1948), in which the princi-
197 pal research agencies were set up; the parliamentary regime that followed (1949–
198 1958), which Gaudillie`re characterises as a period of consolidation; and f nally the
199 new authoritarian republic under De Gaulle (1958–1967), in which increased funding
200 for research was matched by the growing power of the State. However, Inventer la
201 biome´decine does not follow the linear structure of institutional histories such as
202 those by, for example, Picard (Picard, 1990). Instead, as the author describes it him-
203 self, it is a ‘mosaic’ (pp. 20–1). Although it might be possible to justify such a
204 structure by arguing that the French biomedical complex was itself a mosaic
205 (something Gaudillie`re does not actually do, but which I attempt below), it has the
206 effect of presenting a fragmented picture of French biomedicine.
207 2. French biomedicine as a ‘mosaic’
208 In an article on the Pasteur Institute and the development of microbiology in
209 France, Ilana Lo¨wy , a long-standing collaborator with Gaudillie`re, used the term
210 ‘mosaic’ to describe the Pasteur Institute, the largest institute of biological and medi-
211 cal research in France before the Second World War (Lo¨wy, 1994). It could thus be
212 argued that this description is valid, at least until the war, for the French system as
213 a whole, which has been described as ‘hopelessly fragmented’ in terms of its politics
214 (Mulholland, 1991, p. 3), and ‘unintegrated’ in terms of its science (Zallen, 1989,
215 p. 57). Lo¨wy proposed that from its very beginning the Pasteur Institute was ‘a
216 complex mosaic of heterogeneous material and social practices’ (Lo¨wy, 1994, p.
217 664). However, she also maintained that the circulation of micro-organisms, as a
218 specif c set of objects and practices that ‘cemented’ the mosaic together, gave internal
219 coherence to the Institute and linked it with external sites and with extra-mural
220 social groups.
221 After the war, the inf uence of the Pasteur Institute remained considerable.7 How-
222 ever, it ceased to be an exception, and became part of the constellation of institutions
223 that made up the French biomedical complex (p. 34). One might, therefore, hypothes-
224 ize that Gaudillie`re’s book imitates its object and that, consequently, it too is a
225 mosaic. What appears to have cemented the mosaic of French biomedicine together
226 are the molecular tools and concepts that French biologists and clinicians came to
227 share (pp. 12–13), and the collaborative research practices they adopted through
228 contact with their American colleagues, despite continuing tensions between the lab-
229 oratory and the clinic. In the Prologue, Gaudillie`re describes the visits made by
230 French scientists to the United States at the time of the Liberation, in particular those
231 of Louis Bugnard, director of the Institut National d’Hygiene (INH) created under
232 Vichy, and Jacques Monod, a biochemist from the Pasteur Institute and Rockefeller
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233 grantee. These visits were facilitated by the presence of Louis Rapkine at the head
234 of the French scientif c mission in New York, and from 1944 in London.
235 Chapter one describes the research on and production of antibiotics, especially
236 penicillin, which was studied through the ‘missions de la pe´nicilline’ to Britain and
237 to the United States, and which underpinned the postwar reconstruction of the bio-
238 logical and medical sciences in France, as it did in many other Western countries.
239 Chapter three focuses on the viruses and the ultracentrifuge used by Pierre Le´pine
240 at the Pasteur Institute to develop an alternative to Jonas Salk’s polio vaccine. Chap-
241 ter four deals with the electron microscope, and its role in the controversy about the
242 viral origins of cancer that was played out in institutions such as the Insitute for
243 cancer research in Villejuif. Chapter seven concerns the colibacillus and other mol-
244 ecular systems in the work of Jacques Monod. Chapter eight is on ‘boundary objects’
245 such as RNA and their place in networks of French biochemists. Other chapters
246 include investigations of the role of the State (Chapters two and eight), and studies
247 of clinical genetics and medical statistics (Chapters f ve and six).
248 Throughout, Inventer la biome´decine pays special attention to the transfer of
249 American instruments, materials, and results, and compares research practices in
250 France and America. However, while the Prologue and the f rst chapter f ow one
251 from the other, following an obvious chronological order linking them to the Second
252 World War and post-war reconstruction, the rest of the book jumps from one topic
253 to the next. It thus becomes diff cult to keep track of the chronology laid out on p.
254 20. In his introduction (pp. 7–21) and general conclusion (pp. 369–381), Gaudillie`re
255 draws out what he sees as the broad characteristics of the French biomedical com-
256 plex. In the two sections that follow, I summarize and discuss his arguments about
257 the nature and rise of French biomedicine, arguments which are central to Inventer
258 la biome´decine.
259 3. The rise of the French biomedical complex
260 The f rst of these arguments is that French biomedecine was invented between
261 1945 and 1965 as part of the postwar reconstruction of France, and was directly
262 inspired by the American biomedical complex (p. 16). However, what actually com-
263 prised biomedicine was hotly contested, particularly in concerns over the balance to
264 be achieved between experimental, clinical, and social medicine (p. 14). Similarly,
265 of the different actors, whether biologists, clinicians, public health off cials, or man-
266 agers of pharmaceutical companies (p. 15), it was not obvious at the outset who
267 would come to play the greatest role in building French biomedicine.
268 Of all these actors, Picard has drawn historians’ attention to the new generation
269 of clinicians (Picard, 1994). After a f rst, failed rendez-vous between medicine and
270 biology in 1945, at last they succeeded in creating physio-pathological laboratories
271 inside French hospitals under the leadership of Robert Debre´, who was active in
272 research as well as in the political arena (Picard, 1994, pp. 338–340). The rapproche-
273 ment between biology and medicine that was embodied in these laboratories, and
274 which led to the new entity of ‘biomedicine’, a term coined in the early 1960s,
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275 culminated in the foundation of the Institut National de la Sante´ et de la Recherche
276 Me´dicale (inserm) in 1964. However, Picard has argued that inspired by the model
277 of the British Medical Research Council (mrc) that Rapkine introduced to French
278 visitors through the Mission Scientif que, inserm has leaned towards an experimental
279 rather than clinical interpretation of medicine (ibid., pp. 342–343).
280 By contrast, and perhaps in order to explain such an outcome, Gaudillie`re privi-
281 leges the role of biologists among all the men in white coats—les ‘hommes en blouses
282 blanches’, of which he was one himself before becoming a historian (p. 17)—who
283 participated in the construction of French biomedicine after the Second World War.
284 According to Gaudillie`re, 1945 was not a ‘failed rendez-vous’. On the contrary, it
285 was a double rendez-vous, between French and American science and technology
286 as well as between biology and medicine. To Gaudillie`re, the period of the Liberation
287 and of postwar reconstruction presented favourable conditions for the expansion of
288 the biological sciences, sciences which in the era of Big Science benef ted from the
289 new role of the state as provider of healthcare (p. 371). This period was therefore
290 crucial to the emergence of French biomedicine, in which the biological has come
291 to dominate over the medical. Thus, between 1945 and 1965, the relationship
292 between hospitals and biological laboratories was altered, and the biological labora-
293 tory became the key site of production of medical knowledge (p. 9). Such a reversal
294 in the polarity of the system was made possible by the molecularisation of biology
295 and medicine (Abir-Am, 1997; de Chadarevian and Kamminga, 1998), which meant
296 that biologists and clinicians came to share the same research tools, and the same
297 molecular vision of life (pp. 12–13).
298 Thus, although Gaudillie`re alludes to a number of collaborative relationships
299 between French and American scientists that pre-dated the Second World War, often
300 thanks to Rockefeller grants, his focus on the postwar period leads him to play down
301 the continuities with the interwar period. This contrasts with Debru and Gayon’s
302 argument that between the wars the ground was laid for the renewal of several bio-
303 logical and medical disciplines after the Second World War (Debru & Gayon, 1994,
304 pp. 11–12), an argument picked up by Morange in relation to the French school of
305 molecular biology (Morange, 1998, p. 151). Gaudillie`re also downplays the wartime
306 experiences of French scientists, both in exile and under Vichy, which are nonethe-
307 less mentioned in a number of his case studies. Finally, his focus on the biological,
308 rather than the medical, leads him to play down the role of clinicians. However,
309 when attempting to distinguish the French biomedical complex from its American
310 counterpart, he brings French clinicians to the fore.
311 4. The nature of the French biomedical complex: French biomedicine in
312 comparative perspective
313 In addition to examining the impact of American inf uence, Gaudillie`re highlights
314 the particularities of the French context, enabling him to def ne the French biomedical
315 complex through comparing and contrasting it with its American counterpart. Among
316 these particularities, he emphasizes the role of the ‘ne´oclinicien’, who was more
1
12
1
2
3
4
5
6
1 82
3
317 indifferent to America than his biological colleague (p. 376), and who acted as a
318 brake on the transfer of methods, especially medical statistics, from the English-
319 speaking world to France. These methods accompanied the shift in emphasis from
320 infectious to chronic diseases in public health debates, and played a crucial role in
321 the organisation of the modern, randomized clinical trial (Berridge, 1998; Matthews,
322 1995). Thus, although this new generation of clinicians were more attentive to the
323 laboratory sciences than their predecessors (the ‘grand cliniciens’), in the period
324 under consideration, they remained wary of medical statistics (judging them ‘too
325 abstract’, p. 370), of randomized trials (‘too bureaucratic’), and of a chemical
326 approach to therapy (‘too reductionist’). This interesting conclusion would have mer-
327 ited further development, for the molecular tools and vision which French clinicians
328 and biologists came to share in the age of biomedicine coincided with the rise of
329 chemotherapy (p. 370), of which neo-clinicians nevertheless remained suspicious
330 (p. 372).
331 Gaudillie`re also identif es particularities related to the organisation of science in
332 France. He points out the relative absence of charitable organisations and philan-
333 thropic societies, and, by contrast, the overwhelming presence of the State. These
334 particularities enable Gaudillie`re to highlight some intriguing paradoxes. To the
335 French observer, the American situation is curious in that it has combined loose
336 administrative control of research with massive investments and a powerful regulat-
337 ory framework through agencies such as the Food and Drug Administration (p. 316).
338 Conversely, in France, the State has lent its structures and practices of central man-
339 agement to the organisation of the biomedical complex, but has paid little attention
340 to therapeutic intervention and to public health. One of the most important conse-
341 quences of the centralized and state-controlled nature of the French biomedical com-
342 plex, def ned in contrast with the American biomedical complex, has been that phar-
343 maceutical companies have been relegated to its margins. Gaudillie`re contrasts this
344 with the ‘Anglo-Saxon’ model (p. 112), in which industry is a much more powerful
345 partner. Another consequence is the lesser importance that has been accorded to
346 clinical trials and to medical statistics. This time, Gaudillie`re contrasts France with
347 Britain, where the National Health Service provided a fertile ground for the develop-
348 ment of trials and statistics, and where statisticians have played a key role in their
349 capacity as experts advising government on health policy (pp. 244–245, 377–380).
350 Britain, therefore, is not absent from Gaudillie`re’s analysis, although it is often
351 subsumed under the epithet ‘Anglo-Saxon’. No doubt this is an actors’ category, but
352 Gaudillie`re does not appear to acknowledge it as such. It is a pity, for his description
353 suggests that in the immediate post-war period at least, the rise of French biomedicine
354 was the product of a triangular relationship between France, the United States, and
355 the United Kingdom, although in a Cold War context the balance shifted in favour
356 of transatlantic, rather than cross-Channel exchanges. Exploring this relationship in
357 greater depth might have provided some very interesting insights into the internal
358 dynamics of the victorious Allied camp, and its links with the growth of biomedicine
359 in the postwar period (for a tri-partite comparison in relation to molecular biology,
360 see Abir-Am, 2001).
361 Also missing from Inventer la biome´decine is a clear sense of the role of the
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362 French pharmaceutical industry. Although Gaudillie`re recognizes this omission, and
363 accounts for it by explaining the diff culty of access to company records (p. 380),
364 he makes little use of company histories and other secondary sources that might
365 have been helpful in his conclusion. The history of Rhoˆne-Poulenc’s neuroleptic
366 drug chlorpromazine, in particular, would have provided him with a useful counter-
367 example (see Caldwell, 1970, Swazey, 1974, and Baverey, work in progress). Indeed,
368 chlorpromazine helped to establish ideas about the chemical aspects of mental illness,
369 created a new branch of psychology and/or pharmacology—psychopharmacology—
370 and transformed psychiatric care not only in France, but also in the United States,
371 despite the strength of its psychoanalytical tradition. Therefore it represents one
372 instance in which French clinicians (the naval surgeon Henri Laborit, and the psy-
373 chiatrists Jean Delay and Pierre Deniker) were the driving force behind a chemical
374 approach to therapy. Moreover, with support from the French chemical group Rhoˆne-
375 Poulenc—which far from being relegated to the periphery, was at the centre of the
376 innovation process with chlorpromazine—they successfully exported this approach,
377 f rst from France to Britain via the French f rm’s British subsidiary, May & Baker.
378 America quickly followed, in a move facilitated by the French group’s relationship
379 with the American pharmaceutical company SmithKline&French (see Swazey, 1974,
380 Ch. 7; also Quirke, 1999, pp. 237–244). The example of chlorpromazine would have
381 been all the more appropriate in that it presents yet another instance of a reversal
382 of direction in translatlantic exchanges, the best known example being molecular
383 biology (Ch. 7, esp. pp. 276–289), on which Gaudillie`re wrote his doctoral thesis in
384 1991 (Gaudillie`re, 1991).
385 5. The singular case of molecular biology?
386 Unlike one of his actors, the biochemist Georges Cohen (pp. 270–271) who
387 described the ‘transatlantic ballet of scientists’ that began in 1946 with the f rst Cold
388 Spring Harbor symposium following the war (Cohen, 1986), and unlike Abir-Am,
389 who situates the rise of molecular biology between 1938 and 1973 primarily within
390 an international and transdisciplinary space (Abir-Am, 1992), Gaudillie`re distingu-
391 ishes between two phases in the history of transatlantic exchanges in molecular
392 biology. On his account, the direction of these exchanges was reversed from France
393 to America after the 1961 Cold Spring Harbor meeting on the metabolic regulation
394 of micro-organisms (p. 276). This was the f rst symposium which Franc¸ois Jacob
395 and Jacques Monod (who were jointly awarded the Nobel Prize for Physiology or
396 Medicine with Andre´ Lwoff in 1965) attended together. Between 1961 and 1965,
397 their manuscripts and publications covered the desks of American biochemists and
398 geneticists. Such a reversal in the direction of transatlantic exchanges was unusual
399 not only within the context of the Pasteur Institute, but within the French context
400 as a whole (p. 278). Gaudillie`re attributes the success of the experimental system
401 set up by Monod and his group in the late 1950s and early 1960s that led to the
402 discovery of messenger RNA partly to fruitful ‘intrapastorian’ collaborations (p.
403 283), and partly to well-established transatlantic networks. The latter enabled Mon-
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404 od’s group to mobilize resources and information unavailable to other French bio-
405 chemical laboratories at the time. They also made it possible for the group’s results
406 to gain prompt acceptance in the international (mostly Anglo-American) arena, even
407 though they retained the mark of the local context in which they were produced
408 (p. 288).
409 Alongside de Chadarevian’s study of the Laboratory of Molecular Biology in Cam-
410 bridge, which between the 1950s and 1960s became an ‘obligatory passage point’
411 for would-be molecular biologists from America and elsewhere (de Chadarevian,
412 2002, p. 2), Inventer la biome´decine prompts important questions about the post-
413 war reconstruction of European sciences, and about the place of molecular biology
414 in this reconstruction. Why was the direction of transatlantic exchanges reversed in
415 molecular biology, not only from France, but also from Britain to America, at a time
416 when the United States were the centre of ‘molecular biology’s rise to power’ (Abir-
417 Am, 1997, p. 516)? Was this simply an early sign of what was to come in the post-
418 Cold War period—the ‘global village’ of the biotech era—or was it something more?
419 Despite the importance of international exchanges and networks in the making of
420 the new discipline, these reversals suggest that molecular biology offered a privi-
421 leged, although not unique, site for the ‘Europeanisation’ of the biomedical sciences,
422 at a time when much of Western Europe was being exposed to American power and
423 inf uence. Perhaps an accidental side-effect of, as well as a reaction against the much-
424 decried “brain-drain”, this Europeanisation was symptomatic of the political and cul-
425 tural meaning with which molecular biology, more than any other discipline, became
426 invested in the post-war/Cold War period. This led to the creation of the European
427 Molecular Biology Organisation (embo) in the 1960s, followed by the European
428 Molecular Biology Laboratory (embl) in the 1970s. In both these institutions French
429 and British molecular biologists played an important role, the latter at a time when
430 Britain was entering the fold of the European Community. Nevertheless, if the plan
431 to build a European laboratory of molecular biology succeeded, it was also because
432 it received the backing of the United States, which in the wake of Sputnik and the
433 Cuban crisis saw embo and embl as a means of strengthening Western European
434 science (on this see de Chadarevian, 2002, pp. 254–257, 325–333; also Strasser,
435 2002, and Krige, 2002).
436 Although it does not address these questions, Inventer la biome´decine has the
437 great merit of presenting a dynamic picture of the development of molecular biology
438 in France, and of situating the discipline within the wider context of French biomed-
439 icine. I therefore have little doubt that it will stimulate many debates about the rise
440 of national biomedical complexes, about the role of different categories of actors,
441 and about the relative importance of different scientif c disciplines and medical
442 specialisms. I look forward to it being translated into English, for the description it
443 offers of America ‘in the mirror of France’ will be a most welcome addition to the
444 ‘Anglo-Saxon’ literature on the subject. It might also provide a useful model for
445 similar histories, most notably of the rise of the British biomedical complex, which,
446 I suspect, would present many parallels with the French experience.
1
12
1
2
3
4
5
6
1 112
3
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